User:Wikibaruch/Collaborative drug discovery
| Company type | Private |
|---|---|
| Industry | Life Sciences, Informatics |
| Founded | 2004 |
| Headquarters | Burlingame, CA |
| Products | CDD Vault, CDD Collaborate, CDD Public, |
| Website | www.collaborativedrug.com |
Collaborative Drug Discovery (CDD) is a software company founded in 2004 as a spin-out of Eli Lilly by Barry Bunin, PhD. CDD offers a web-based database solution for managing drug discovery data, primarily around small molecules and associated bio-assay data. CDD's primary offering is the CDD Vault, which allows scientists to maintain a private and secure collection of their data. The system is unique in its capability to facilitate private collaboration via CDD Collaborate, where individual research groups can securely share subsets of data with one another. CDD also offers CDD Public, a free database for fostering open collaboration containing over 3 million molecules accessible to everyone in the drug discovery community at large. [1]
The capability for inter-group collaboration attracted attention from the Bill & Melinda Gates Foundation, who in 2008 awarded CDD with a two million dollar grant being used to provide the database to researchers combating the deadly infections disease Tuberculosis. [2]
In 2010, pharmaceutical company GlaxoSmithKline released 13,471 molecules screened for activity against Malaria to the public. These molecules and their associated screening data are available via CDD Public, as well as the National Library of Medicine's PubChem, and the European Bioinformatics Institute's ChEMBL database. [3]